• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
    • Dynamic Chiropractic
      • Newspaper
      • Subscription
    • The American Chiropractor
      • Magazine
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Sponsored Content
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
    • Coronavirus (COVID-19)
  • Resource Centers
  • Products & Services
    • Buyers Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students

Statement from UAS Laboratories president regarding recent FDA action

Chiropractic Economics June 15, 2011

UAS_Laboratories_LogoIn response to certain information contained on the UAS Laboratories website, the FDA seized UAS Labs’ products last week. UAS Labs is diligently working with the FDA to correct this information. In the interim, it is important for our customers, vendors, and colleagues to understand the facts.

1. Our product is not under question. Our facilities were recently inspected by the FDA and our products are safe and effective. People do not need to worry about the probiotics they are taking.

2. What is at issue with the FDA are certain statements made on our website that the FDA believes expand our labeling to imply that our products can be used to treat or cure certain health conditions.

We are removing and/or modifying this language to be in compliance with FDA requirements and are working with the FDA to resolve this issue. We are in contact with our FDA representatives and expect to resolve this matter very soon. While we respect the FDA’s position, it is unfortunate that the matter could not have been resolved with a phone call or warning letter before taking action.

Source: Dr. Dash – UAS Laboratories, www.uaslabs.com

Related Posts

  • Low level laser therapy investigated as treatment for arthritis painLow level laser therapy investigated as treatment for arthritis pain
  • Most overlook this one factor tied to personal growthMost overlook this one factor tied to personal growth
  • How to Streamline Your Patient Check-in Process with CTSign-In and Front DeskHow to Streamline Your Patient Check-in Process with CTSign-In and Front Desk
  • Patient education to increase your patient retention ratePatient education to increase your patient retention rate
  • NUHS faculty member participates in NBCE physiotherapy test committeeNUHS faculty member participates in NBCE physiotherapy test committee
  • From chiropractic student to doctor: the path you choose is yoursFrom chiropractic student to doctor: the path you choose is yours

Filed Under: Industry News, News

Current Issue

CE issue 5 cover

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

Compare Subscriptions

Dynamic Chiropractic

The American Chiropractor

3948 3rd Street South #279,

Jacksonville Beach, FL 32250

Phone 904.285.6020

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Cleveland University-Kansas City Launches New Continuing Education Website
  • New Report Cites Nutrition Response Testing® Helping Chiropractors Increase Value and Results
  • Military Husband and Wife Team Set to Expand The Joint Chiropractic into Puerto Rico